课题基金 / 基金详情

Research on Advance directives of Amyotrophic Lateral sclerosis Patient and QOL

Research on Advance directives of Amyotrophic Lateral sclerosis Patient and QOL
肌萎缩侧索硬化症患者的预先指示及生活质量研究
批准号:
16590417
负责人:
ITO Michiya
金额:
$0.9万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2004
资助国家:
日本
项目状态:
已结题
起止时间:
2004 至 2005

项目摘要

项目成果

ITO Michiya的其他基金

相似基金

相关文献

中文摘要
翻译
肌萎缩性侧索硬化症患者预嘱与qol1研究结果:(1)患者回复(N=300)中,预嘱的优点(多答)是有序的(18%“为了满足他的希望而进行谈话”,16%“符合他的要求并推进了医疗”,15%“分享了自我决定的内容”,14%“他/她、家人和医疗人员的沟通变得良好”,12%“不是不希望的强制医疗”)。护士(305名)和医生(265名)的回答也大致相同。(2)虽然“只有医生才能决定治疗政策”、“尚未习惯自我决定”、“对决定内容不熟悉”、“形式不规范”、“没有法律依据”等顺序是预嘱未传播的预防因素(多重回答),但医生对“没有法律依据是什么”存在怀疑的倾向。(3)关于预嘱传播的政策,虽然(多次回答)在患者回复中“检查内容更新和重写”的比例为11%,“信息充实”的比例为24%,“促进通知”的比例为18%,随后为“促进通知”的比例为19%,医生重视“法律依据”的比例为17%。(4)虽然是预嘱的呈现方式,但在患者答复中,顺序为“口头”、“文件”、“医院原始形式”、“手写备忘录”,且文件多与口头相抗衡。最多为3次,尽管约30%的患者答复说存在重写预嘱内容的情况。
英文摘要
Research on Advance directives of Amyotrophic Lateral sclerosis Patient and QOLResult: (1)The merit (multiple answers) of Advance directives is order (18%"talks are made in order to fulfill his hope", 16% "it complies with his/her request and medical treatment is advanced", 15%"contents of self-determination are shared", 14% "that communication of his/her, family, and medical stuff becomes good", and 12% "it is not forced medical treatment which is not desired" ), in patients' reply (N=300). It is the same as that also of nurses (N=305) and doctors (N=265) reply almost. (2) Although the prevention factor (multiple answers) through which Advance directives do not spread was the order of "only a doctor may decide treatment policy", "it not having got used to self-determination", "it not being well-known to a decision content", "the form not being standardized", and there "there being no legal basis" in the patient reply, the tendency to regard as questionable what "no legal basis is" was seen in the doctor. (3) About the policy of Advance directives spread, although (multiple answers) are 11% of order "which checks renewal of contents, and rewriting" in a patient reply 24% "information is made substantial", and 18% "which promotes a notice", subsequently to 19% "which promotes a notice", the doctor attaches importance to "legal-basis" 17%. (4) Although it is the presentation method of Advance directives, in the patient reply, it is the order of "oral", a "document", "the original form of a hospital", and a "handwriting memorandum", and the document has rivaled oral mostly. Maximum is 3 times although about 30 % has answered by the patient reply that the existence of rewriting of the contents of Advance directives.
期刊论文(48)
专著(0)
科研奖励(0)
会议论文
Michiya Ito About the importance of the counseling in the gene diagnosis of familial adenomatous polyposis
伊藤道也谈家族性腺瘤性息肉病基因诊断中咨询的重要性
DOI: --
发表时间: 2005
期刊: Japan Journal of Familial cancer 5(2)
影响因子: --
作者: [Tomoko Saeki, Hideki Ishikawa, Ayako Nasu]
通讯作者: Ayako Nasu
電子カルテの羅針盤
电子病历指南针
DOI: --
发表时间: 2005
期刊: 看護部長通信 2(6)
影响因子: --
作者: [Hiroshi Kaneda, et al., 伊藤道哉]
通讯作者: 伊藤道哉
New deployment about Advance directives
关于预先指示的新部署
DOI: --
发表时间: 2005
期刊: Crecon report 27
影响因子: --
作者: [Ding H, Koinuma N, Ito Michiya]
通讯作者: Ito Michiya
DOI: --
发表时间: 2004
期刊: 看護部長通信 2(1)
影响因子: --
作者: [Rintaro Tsukahara, et al., 伊藤道哉]
通讯作者: 伊藤道哉
共 22 条
    Research on the diffusion of Advance directives of ALS (Amyotrophic lateral sclerosis) patients by designation as Proxy decision maker
    Ethical and social study on the care for ALS-D (ALS with dementia) patients and thier family
    • 批准号:
      25670239
    • 项目类别:
      Grant-in-Aid for Challenging Exploratory Research
    • 资助金额:
      $2.5万
    • 财政年份:
      2013
    • 负责人:
      ITO Michiya
    • 依托单位:
    Socio-medical research on the effects of the legalization to discontinue life-sustaining treatment
    • 批准号:
      23659248
    • 项目类别:
      Grant-in-Aid for Challenging Exploratory Research
    • 资助金额:
      $2.16万
    • 财政年份:
      2011
    • 负责人:
      ITO Michiya
    • 依托单位:
    Research on Economical Evaluation of Genetic Testing Diagnosis of Familial Cancer
    • 批准号:
      14572122
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $1.02万
    • 财政年份:
      2002
    • 负责人:
      ITO Michiya
    • 依托单位:
    海外基金